C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2011
08/25/2011	WO2011055215A3 Novel benzopyran kinase modulators
08/25/2011	WO2011046964A3 Inhibitors of bruton's tyrosine kinase
08/25/2011	US20110207924 New phenanthrylphenol linked pyrrolo [2, l-c] [l, 4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
08/25/2011	US20110207757 Tricyclic Compounds Having Cytostatic and/or Cytoxic Activity and Methods of Use Thereof
08/25/2011	US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	US20110207751 Heterocyclic compounds and uses as anticancer agents
08/25/2011	US20110207740 Pharmaceutical compositions
08/25/2011	US20110207736 Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
08/25/2011	US20110207721 Purine derivatives as kinase inhibitors
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators
08/25/2011	US20110207712 Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110206613 METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
08/25/2011	US20110206607 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
08/25/2011	CA2827694A1 Cyclic tetrapeptides and therapeutic applications thereof
08/25/2011	CA2790641A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	CA2790637A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	CA2790155A1 Pyrazole derivatives as jak inhibitors
08/25/2011	CA2790070A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	CA2789058A1 Piperidine derivatives
08/25/2011	CA2788783A1 Heterocycles as potassium channel modulators
08/25/2011	CA2788072A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
08/25/2011	CA2787304A1 Substituted spiroindolinones
08/25/2011	CA2787083A1 Androgen receptor modulators and uses thereof
08/24/2011	EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/24/2011	EP2360158A1 Pyrazole derivatives as jak inhibitors
08/24/2011	EP2360155A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
08/24/2011	EP2358723A1 Organic compounds
08/24/2011	EP2358722A1 Nitrogenous heterocyclic compounds, preparation thereof, and use thereof as antibacterial agents
08/24/2011	EP2358721A1 Modulators of cystic fibrosis transmembrane conductance regulator
08/24/2011	EP2358720A2 Fused ring heteroaryl kinase inhibitors
08/24/2011	EP2358719A1 Novel pyrroiol2,l-cu1.41benzodiazepine derivatives with dithiocarbamate side chains and process for the preparation thereof
08/24/2011	EP2358718A1 Mtor kinase inhibitors for oncology indications and diseases associated with the mtor/p13k/akt pathway
08/24/2011	EP2358717A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
08/24/2011	EP2358716A1 Inhibitors of fatty acid binding protein (fabp)
08/24/2011	EP2358715A1 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
08/24/2011	EP2358714A1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/24/2011	EP2358713A1 Imidazopyridazine derivatives acting as orexin antagonists
08/24/2011	EP2358712A1 Piperidine derivatives useful as orexin receptor antagonists
08/24/2011	EP2358711A1 Piperidine derivatives useful as orexin receptor antagonists
08/24/2011	EP2358684A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
08/24/2011	EP2358677A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
08/24/2011	EP2358204A1 Organic compounds
08/24/2011	EP1558616B2 Meso-substituted porphyrins
08/24/2011	CN102164925A Tricyclic oxazolidinone antibiotic compounds
08/24/2011	CN102164604A Fused heterocyclic compounds useful as kinase modulators
08/24/2011	CN102161662A Artificially synthesized antigen of sildenafil and derivatives thereof as well as preparation method and application of antigen
08/24/2011	CN102160864A Improved cancer treatment with temozolomide
08/24/2011	CN101563348B A process for the preparation of sildenafil and the intermediates thereof
08/23/2011	US8003802 Total synthesis of Salinosporamide A and analogs thereof
08/23/2011	US8003785 Halo-substituted pyrimidodiazepines
08/23/2011	US8003659 Macrocyclic serine protease inhibitors
08/23/2011	US8003656 2-phenoxy pyrimidinone analogues
08/23/2011	US8003649 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
08/23/2011	US8003647 (Aza)indole derivative and use thereof for medical purposes
08/23/2011	US8003646 Substituted triazolo-pyridazine derivatives
08/23/2011	CA2520008C Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
08/23/2011	CA2489452C Phenylaminopyrimidines and their use as rho-kinase inhibitors
08/23/2011	CA2484070C Antibacterial compositions comprising metal phthalocyanine analogues
08/18/2011	WO2011100402A1 Macrocycles as factor xia inhibitors
08/18/2011	WO2011100401A1 Macrocycles as factor xia inhibitors
08/18/2011	WO2011100380A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
08/18/2011	WO2011099718A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/18/2011	WO2011099602A1 Porphyrin derivative and use thereof in radiation induced photodynamic therapy
08/18/2011	WO2011099451A1 Organic electroluminescent element
08/18/2011	WO2011099374A1 Organic electroluminescent element
08/18/2011	WO2011098971A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/18/2011	WO2011082267A8 Substituted triazolo-pyrazine compounds
08/18/2011	WO2011047320A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047319A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
08/18/2011	WO2011041399A3 Pi3k (delta) selective inhibitors
08/18/2011	US20110201807 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same
08/18/2011	US20110201804 Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
08/18/2011	US20110201803 Pyrrolobenzodiazepines
08/18/2011	US20110201631 Pharmaceutical formulations comprising pemetrexed
08/18/2011	US20110201628 Heterocyclic jak kinase inhibitors
08/18/2011	US20110201600 Chalcone linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
08/18/2011	US20110201595 Oxazolidinyl antibiotics
08/18/2011	US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011	US20110197969 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
08/18/2011	CA2789622A1 Macrocycles as factor xia inhibitors
08/18/2011	CA2787881A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
08/18/2011	CA2787823A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
08/17/2011	EP2357184A1 Imidazoquinoxaline compounds as immunomodulators
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP2356123A1 Spiro-5,6-dihydro-4h-2,3,5,10b-tetraaza-benzo[e]azulenes
08/17/2011	EP2356122A1 Protein kinase inhibitors
08/17/2011	EP2356121A1 Process for resolving zopiclone
08/17/2011	EP2356113A1 Heterocyclically substituted aryl compounds as hif inhibitors
08/17/2011	EP2356109A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
08/17/2011	EP2356101A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
08/17/2011	EP2356093A1 Carbazole compounds and therapeutic uses of the compounds
08/17/2011	EP1904497B1 Substituted rylene derivatives
08/17/2011	EP1683847B1 Allergen decomposer and antiallergenic feather
08/17/2011	CN1878766B Methods for synthesizing quinolinone compounds
08/17/2011	CN102159577A Imidazo[1,2-a]pyrimidine derivatives, method for preparation thereof, use thereof as medicaments, pharmaceutical compositions and met inhibitors
08/17/2011	CN102159548A Amide compounds useful in therapy
08/17/2011	CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof

1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 573